EE704 Risdiplam for the Treatment of Spinal Muscular Atrophy: Impact on the National Healthcare Service During the First 15 Months of Commercialization in Italy
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.969
https://www.valueinhealthjournal.com/article/S1098-3015(23)04099-8/fulltext
Section Title :
Section Order :
10465
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04099-8&doi=10.1016/j.jval.2023.09.969